GLAXOSMITHKLINE PLC

GSK
Real-time Estimate Quote. Real-time Estimate  - 08/07 11:30:00 am
1554.1GBX +0.26%

GlaxoSmithKline : REFILE-Sanofi, Glaxo advance talks to supply up to 300 mln COVID-19 vaccine doses to Europe -companies

07/31/2020 | 03:51pm

July 31 (Reuters) - Sanofi SA and GlaxoSmithKline Plc on Friday said they are in advanced discussions with the European Commission to supply up to 300 million doses of the drugmakers's experimental COVID-19 vaccine.

The doses would be manufactured in European countries including France, Belgium, Germany and Italy.

Sanofi is leading the clinical development of the vaccine and expects to launch a pivotal trial by the end of this year. (Reporting By Deena Beasley; editing by Grant McCool)

Thomson Reuters 2020
Copier lien
Latest news on GLAXOSMITHKLINE PLC
14h ago
1d ago
1d ago
1d ago
4d ago